Curatis Holding AG (XSWX:CURN) Research & Development: CHF0.14 Mil (TTM As of Dec. 2025)


XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Research & Development?

Curatis Holding AG XSWX:CURN +3.51% 33 Research & Development is CHF0.14 Mil as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Curatis Holding AG's Research & Development for the six months ended in Dec. 2025 was CHF-0.55 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.14 Mil.

Curatis Holding AG  (XSWX:CURN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Curatis Holding AG Research & Development Related Terms

Curatis Holding AG Research & Development Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Research & Development Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 1.51 0.72 0.30 0.14

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.00 0.30 0.69 -0.55
XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0.14 Mil mean?
Curatis Holding AG (XSWX:CURN) has a Research & Development of CHF0.14 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Curatis Holding AG and its competitors.
Is Curatis Holding AG's Research & Development too high?
Curatis Holding AG's current Research & Development is CHF0.14 Mil. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Research & Development compare to ZTS and UTHR?
Curatis Holding AG's Research & Development of CHF0.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Curatis Holding AG and its competitors. Curatis Holding AG's current Research & Development is CHF0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Research & Development of CHF0.14 Mil. The current Research & Development is CHF0.14 Mil. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Research & Development is CHF0.14 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price